IMPAX Laboratories, Inc. (IPXL) Launches Authorized Generic of Zomig (zolmitriptan) Tablets and Orally Disintegrating Tablets in the U.S.
5/17/2013 9:46:12 AM
More...
|
IMPAX Laboratories, Inc. (IPXL) to Present at the Bank of America (BAC) Merrill Lynch 2013 Health Care Conference
5/10/2013 7:48:17 AM
More...
|
IMPAX Laboratories, Inc. (IPXL) Reports First Quarter 2013 Results
5/2/2013 8:03:19 AM
More...
|
GlaxoSmithKline (GSK), IMPAX Laboratories, Inc. (IPXL) End Collaboration on IPX066 Parkinson's Treatment
4/29/2013 7:08:59 AM
More...
|
IMPAX Laboratories, Inc. (IPXL) Schedules Conference Call and Webcast for First Quarter 2013 Financial Results
4/3/2013 11:58:14 AM
More...
|
IMPAX Laboratories, Inc. (IPXL) Continues to Ignore FDA Warnings, Causing Delays
3/15/2013 7:03:03 AM
More...
|
FDA Finds Problems Continue at IMPAX Laboratories, Inc. (IPXL) Factory in Hayward
3/6/2013 8:13:30 AM
More...
|
IMPAX Laboratories, Inc. (IPXL) Provides an Update on FDA Inspection of Hayward Facility
3/5/2013 9:57:57 AM
More...
|
IMPAX Laboratories, Inc. (IPXL) to Present at the Cowen and Company 33rd Annual Health Care Conference
3/1/2013 7:12:20 AM
More...
|
IMPAX Laboratories, Inc. (IPXL) Reports Fourth Quarter and Full Year 2012 Results
2/26/2013 6:41:51 AM
More...
|
|